KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Gross Margin (2020 - 2025)

Moderna (MRNA) has disclosed Gross Margin for 6 consecutive years, with 33.33% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 983.0% to 33.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55.35% through Dec 2025, up 152.0% year-over-year, with the annual reading at 55.35% for FY2025, 59.0% up from the prior year.
  • Gross Margin for Q4 2025 was 33.33% at Moderna, down from 79.63% in the prior quarter.
  • The five-year high for Gross Margin was 92.13% in Q4 2022, with the low at 112.5% in Q2 2023.
  • Average Gross Margin over 5 years is 48.35%, with a median of 67.13% recorded in 2022.
  • The sharpest move saw Gross Margin tumbled -18342bps in 2023, then soared 14716bps in 2024.
  • Over 5 years, Gross Margin stood at 86.8% in 2021, then grew by 6bps to 92.13% in 2022, then dropped by -27bps to 66.95% in 2023, then crashed by -65bps to 23.5% in 2024, then soared by 42bps to 33.33% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 33.33%, 79.63%, and 16.2% for Q4 2025, Q3 2025, and Q2 2025 respectively.